The global demand for Gadoterate Meglumine Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Gadoterate meglumine or gadoteric acid is an intravenous extracellular gadolinium-based magnetic resonance imaging (MRI) contrast agent. It is used for MRI of the brain, spine, and associated tissues to detect and visualize areas with disruption of the blood-brain barrier and abnormal vascularity. It is sold under the trade name Dotarem. Gadoterate meglumine is a sterile, non-pyrogenic, clear, and colorless to the yellow aqueous solution.
Market Dynamics
The global gadoterate meglumine market is projected to grow at a steady rate attributed to the increasing prevalence of brain, spine, and related tissue diseases and the growing use of magnetic resonance imaging (MRI) for diagnosis. MRI is becoming the preferred method for spinal and musculoskeletal imaging. Rising demand for quick and effective diagnostic procedures is expected to contribute towards the adoption of MRI, thus gadoterate meglumine. In addition, increasing awareness about the benefits of early diagnosis, geriatric population, improving healthcare infrastructure, and rising diagnostic facilities are also significant factors complementing market growth. However, other alternatives contrast agents like gadolinium, manganese, and iron oxide are hindering the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gadoterate meglumine. The growth and trends of gadoterate meglumine industry provide a holistic approach to this study.
Market Segmentation
This section of the gadoterate meglumine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- 1.8845Gm/5Ml
- 3.769Gm/10Ml
- 5.6535Gm/15Ml
- Others
By Application
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Gadoterate Meglumine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Gadoterate Meglumine Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gadoterate meglumine market include Guerbet Group, GE, Bayer, Sanochemia, T2Pharma, b.e.imaging GmbH, Hengrui Medicine. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.